(Q40267839)

English

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

scientific article published on 14 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

phase III clinical trial

0 references

0 references

multicenter clinical trial

0 references

tuberous sclerosis

1 reference

based on heuristic

inferred from title

tuberous sclerosis 1

1 reference

based on heuristic

inferred from title

Elena Dmitrievna Belousova

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sergiusz Jóźwiak

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Steven Sparagana

object named as

Steven Sparagana

3

1 reference

ORCID Public Data File 2021

author name string

David Neal Franz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

E Martina Bebin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Michael Frost

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rachel Kuperman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Olaf Witt

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Michael H Kohrman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

J Robert Flamini

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Joyce Y Wu

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Paolo Curatolo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Petrus J de Vries

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Vicky H Whittemore

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Elizabeth A Thiele

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

James P Ford

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Gaurav Shah

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Helene Cauwel

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

David Lebwohl

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Tarek Sahmoud

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

0 references

publication date

14 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

381

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

9861

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

125-132

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Tuberous sclerosis complex: neurological, renal and pulmonary manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberous sclerosis complex: tumors and tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Subependymal giant cell tumors in tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical treatment of intraventricular tumors associated with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The TSC1-TSC2 complex: a molecular switchboard controlling cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus treatment for pulmonary lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

National Institutes of Health consensus conference: tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of everolimus in pediatric patients with refractory solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of subependymal giant cell astrocytomas with RAD001 (Everolimus) in tuberous sclerosis complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Energy balance and puberty onset: emerging role of central mTOR signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(12)61134-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

release_dvyh73o4zbhljf2dcoxcefcfbm

1 reference

https://api.fatcat.wiki/v0/release/dvyh73o4zbhljf2dcoxcefcfbm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23158522%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40267839&oldid=1839113544"